Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens

BACKGROUND: Bedaquiline and delamanid are newly available drugs for treating multidrug-resistant tuberculosis (MDR-TB); however, there are limited data guiding their use and no comparison studies. METHODS: We conducted a prospective, observational study among patients with MDR-TB in Georgia who were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Kempker, R R, Mikiashvili, L, Zhao, Y, Benkeser, D, Barbakadze, K, Bablishvili, N, Avaliani, Z, Peloquin, C A, Blumberg, H M, Kipiani, M
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Major Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7713674/
https://ncbi.nlm.nih.gov/pubmed/31712809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz1107
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados